These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 32650790)

  • 1. Potential pharmacological approaches for the treatment of HIV-1 associated neurocognitive disorders.
    Omeragic A; Kayode O; Hoque MT; Bendayan R
    Fluids Barriers CNS; 2020 Jul; 17(1):42. PubMed ID: 32650790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antineuroinflammatory drugs in HIV-associated neurocognitive disorders as potential therapy.
    Ambrosius B; Gold R; Chan A; Faissner S
    Neurol Neuroimmunol Neuroinflamm; 2019 May; 6(3):e551. PubMed ID: 31119186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of CNS Viral Seeding by HIV
    Veenstra M; León-Rivera R; Li M; Gama L; Clements JE; Berman JW
    mBio; 2017 Oct; 8(5):. PubMed ID: 29066542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The far-reaching HAND of cART: cART effects on astrocytes.
    Gonzalez H; Podany A; Al-Harthi L; Wallace J
    J Neuroimmune Pharmacol; 2021 Mar; 16(1):144-158. PubMed ID: 32147775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications.
    Hong S; Banks WA
    Brain Behav Immun; 2015 Mar; 45():1-12. PubMed ID: 25449672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Elvitegravir Nanoformulation Crosses the Blood-Brain Barrier and Suppresses HIV-1 Replication in Microglia.
    Gong Y; Zhi K; Nagesh PKB; Sinha N; Chowdhury P; Chen H; Gorantla S; Yallapu MM; Kumar S
    Viruses; 2020 May; 12(5):. PubMed ID: 32443728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Advances of immunological pathogenesis research in HIV related neurocognitive disorder].
    Yongjia JI; Hongzhou LU
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May; 45(3):249-55. PubMed ID: 27651188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic approaches to HIV-associated neurocognitive disorders.
    Avedissian SN; Dyavar SR; Fox HS; Fletcher CV
    Curr Opin Pharmacol; 2020 Oct; 54():102-108. PubMed ID: 33049585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Important role of microglia in HIV-1 associated neurocognitive disorders and the molecular pathways implicated in its pathogenesis.
    Borrajo A; Spuch C; Penedo MA; Olivares JM; Agís-Balboa RC
    Ann Med; 2021 Dec; 53(1):43-69. PubMed ID: 32841065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of substance abuse on HIV-mediated neuropathogenesis in the current ART era.
    Chilunda V; Calderon TM; Martinez-Aguado P; Berman JW
    Brain Res; 2019 Dec; 1724():146426. PubMed ID: 31473221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-Associated Neurocognitive Disorder: A Look into Cellular and Molecular Pathology.
    Thompson LJ; Genovese J; Hong Z; Singh MV; Singh VB
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocognitive Impairment in the Combined Antiretroviral Therapy Era in a Romanian Cohort of Young Adults with Chronic HIV Infection.
    Temereanca A; Ene L; Rosca A; Diaconu CC; Luca A; Burlacu R; Radoi R; Bulacu-Talnariu A; Marcotte TD; Achim CL; Ruta S
    AIDS Res Hum Retroviruses; 2020 May; 36(5):367-372. PubMed ID: 31476875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphine exposure exacerbates HIV-1 Tat driven changes to neuroinflammatory factors in cultured astrocytes.
    Chen K; Phan T; Lin A; Sardo L; Mele AR; Nonnemacher MR; Klase Z
    PLoS One; 2020; 15(3):e0230563. PubMed ID: 32210470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of Molecular Properties of Antiretroviral Agents to Enhance CNS Penetration Abilities for the Treatment of Cognitive Impairment in HIV-Associated Neurocognitive Disorder.
    Danta CC; Piplani P
    ACS Chem Neurosci; 2020 Jul; 11(14):2034-2038. PubMed ID: 32573244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of cerebellar neurons in the progression of lentiviral disease: effects of CNS-permeant antiretroviral therapy.
    Wächter C; Eiden LE; Naumann N; Depboylu C; Weihe E
    J Neuroinflammation; 2016 Oct; 13(1):272. PubMed ID: 27737697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Chronicity of HIV Infection Should Drive the Research Strategy of NeuroHIV Treatment Studies: A Critical Review.
    Gates TM; Cysique LA
    CNS Drugs; 2016 Jan; 30(1):53-69. PubMed ID: 26749584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does HIV infection contribute to increased beta-amyloid synthesis and plaque formation leading to neurodegeneration and Alzheimer's disease?
    Fulop T; Witkowski JM; Larbi A; Khalil A; Herbein G; Frost EH
    J Neurovirol; 2019 Oct; 25(5):634-647. PubMed ID: 30868421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV Nef and Antiretroviral Therapy Have an Inhibitory Effect on Autophagy in Human Astrocytes that May Contribute to HIV-Associated Neurocognitive Disorders.
    Cheney L; Guzik H; Macaluso FP; Macian F; Cuervo AM; Berman JW
    Cells; 2020 Jun; 9(6):. PubMed ID: 32526847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV Increases the Inhibitory Impact of Morphine and Antiretrovirals on Autophagy in Primary Human Macrophages: Contributions to Neuropathogenesis.
    Barbaro JM; Cuervo AM; Berman JW
    Cells; 2021 Aug; 10(9):. PubMed ID: 34571832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Inflammasomes in HIV-1 and Drug Abuse Mediated Neuroinflammaging.
    Sil S; Niu F; Chivero ET; Singh S; Periyasamy P; Buch S
    Cells; 2020 Aug; 9(8):. PubMed ID: 32784383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.